Form D · Biotechnology
AMBIO HOLDINGS, INC.
North Augusta, SC · CIK 0001625527
Offering snapshot reported Nov 19, 2014 · SEC filing
- Reported sold
- $24M Offering amount: $24M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 5, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 19, 2014 | Initial | $23,999,970 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-228681
Source: Form D, filed Nov 19, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Juncai Bai | Director, Executive |
| Lewis Geffen | Executive |
| Bosun Hau | Director |
| Stephen Kiel | Director |
| Stephen Reeders | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1024 Dittman Court
North Augusta, SC, 29842
North Augusta, SC, 29842